Inventor · disambiguated record
Deborah Helen Slee
Also filed as: SLEE DEBORAH · SLEE DEBORAH H · SLEE DEBORAH HELEN
18 granted patents·15 pending applications·20 citations·filing 1996–2021
91Inventor score
Files withRECURIUM IP HOLDINGS LLC13NEUROCRINE BIOSCIENCES INC5ZENO ROYALTIES & MILESTONES LLC5KALYRA PHARMACEUTICALS INC3CHEN YOUNGSHENG1
Top patents by PatentIndex Score
33 records- 0187US9718789B2Substituted triazoles and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2016·Granted Aug 1, 2017·3 cites·17 claims
- 0285US10138214B2Substituted triazoles and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2017·Granted Nov 27, 2018·2 cites·20 claims
- 0383US11065234B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·1 cites·32 claims
- 0482US11098030B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Aug 24, 2021·1 cites·13 claims
- 0582US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 0681US10738017B2Substituted triazoles and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2018·Granted Aug 11, 2020·1 cites·23 claims
- 0777US10513509B2EGFR inhibitor compoundsKALYRA PHARMACEUTICALS INC·Filed 2017·Granted Dec 24, 2019·1 cites·24 claims
- 0875US10308609B2Bicyclic compoundsKALYRA PHARMACEUTICALS INC·Filed 2015·Granted Jun 4, 2019·2 cites·22 claims
- 0973US12049460B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted Jul 30, 2024·0 cites·20 claims
- 1073US2021330651A1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1172US10959989B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 30, 2021·0 cites·3 claims
- 1271US10975035B2Bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 1371US10493060B2Spirocyclic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2019·Granted Dec 3, 2019·1 cites·11 claims
- 1470US11065233B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·0 cites·24 claims
- 1570US11021449B2Substituted triazoles and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Jun 1, 2021·0 cites·20 claims
- 1663US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1756US2019142811A1Estrogen receptor modulatorsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 1854US10653681B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted May 19, 2020·0 cites·12 claims
- 1954US7737154B2CRF receptor antagonists and methods relating theretoSMITHKLINE BEECHAM CORK LTD·Filed 2004·Granted Jun 15, 2010·0 cites·19 claims
- 2051US6900238B1HIV protease inhibitorsSCRIPPS RESEARCH INST·Filed 1996·Granted May 31, 2005·6 cites·4 claims
- 2148US2010249084A1Substituted pyrimidines as adenosine receptor antagonistsCHEN YOUNGSHENG·Filed 2008·Application pending·0 cites
- 2247US2008058356A12,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor AntagonistsNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 2347US2007293511A1Crf Receptor Antagonists and MethodsSB PHARMCO PUERTO RICO INC AND·Filed 2004·Application pending·0 cites
- 2446US11242327B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Feb 8, 2022·0 cites·23 claims
- 2545US2010234341A1Substituted pyrimidines as adenosine receptor antagonistsLANIER MARION·Filed 2007·Application pending·0 cites
- 2645US2022389006A1Salts and forms of an estrogen receptor modulatorRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2744US2021094899A1Acrylic acid analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Application pending·0 cites
- 2840US2008275064A1Substituted Pyrimidines as Adenosine Receptor AntagonistsSLEE DEBORAH·Filed 2006·Application pending·0 cites
- 2939US2019083460A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 3039US2019060257A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 3139US2007129382A1Crf receptor antagonists, their preparations, their pharmaceutical composition, and their usesGRIGORIADIS DIMITRI·Filed 2005·Application pending·0 cites
- 3239US2019099404A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 3336US2018201614A1Bicyclic compoundsKALYRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →